-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Immucell Corp /De/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Immucell Corp /De/ Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.39M, a 6.3% decline year-over-year.
- Immucell Corp /De/ Operating Income (Loss) for the twelve months ending June 30, 2024 was -$3.87M, a 33.3% increase year-over-year.
- Immucell Corp /De/ annual Operating Income (Loss) for 2023 was -$5.75M, a 150% decline from 2022.
- Immucell Corp /De/ annual Operating Income (Loss) for 2022 was -$2.3M, a 993% decline from 2021.
- Immucell Corp /De/ annual Operating Income (Loss) for 2021 was $257K.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)